Log In
Print
BCIQ
Print
Print this Print this
 

Zecuity, sumatriptan (formerly NP101, Zelrix)

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionTransdermal patch delivering sumatriptan via iontophoresis
Molecular Target Serotonin (5-HT1) receptor
Mechanism of ActionSerotonin (5-HT1) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationMigraine
Indication DetailsTreat acute migraine with or without aura in adults; Treat migraine; Treat migraine in adolescents
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today